Published by Josh White on 14th May 2020
(Sharecast News) - Specialist drug discovery and development company ImmuPharma updated the market on activities around Covid-19 on Thursday, having expanded its pipeline in late March to include three new 'anti-infective' programmes, one of which was in antivirals.
URL: http://www.digitallook.com/dl/news/story/30667227/...